|
Wednesday 13th October 2021 |
Text too small? |
Company: Greenfern Industries Limited
Issuer Code: GFI
ISIN: NZGFIE0001S4
Short Name: Greenfern Industries
Registered Office: Level 8, General Capital House, 115 Queen Street Auckland, 1040
Website: https://gfi.nz
Telephone Number: +64 (9) 488 8700
Financial Year End: 31 March
Nature of Business: Greenfern is a New Zealand based cannabis, therapeutics and wellness company, incorporated in 2018, and aiming to be a leading New Zealand producer and wholesale distributor of:
• Medicinal cannabis products.
• Hemp-based health beauty products.
• Hemp-based food and other fast-moving consumer goods.
Directors: Brent King (Chair), Daniel Casey, Philip Brown, Darryl Davies, Simon McArley, Kirsten Taylor, Marvin Yee.
Details of Issue: Direct listing of 84,300,384 ordinary shares
Quoted Securities at Date of Listing: 84,300,384 ordinary shares
Reference Price: $0.25
Tick Size: $0.01
Auditors: Crowe
Solicitors: McRae Law Limited
Registrar: Computershare Investor Services Limited
Settlement Status: NZCDC Settlement System
Profile Document Dated: 13 October 2021
Profile available: GFI website, and from 14 October at www.nzx.com/companies/GFI/documents
Expected Commencement of Trading on the NZX Main Board: 21 October 2021, at 11 am
Mark Peterson
Chief Executive Officer
NZX Limited
13 October 2021
Please see the link below for details
L&Q Notice - Greenfern Industries Limited
No comments yet
RAK - 1H26: Strong first half growth and strategic momentum
Green Cross Health Interim Results to 30 September 2025
Devon Funds Morning Note - 28 November 2025
November 28th Morning Report
Pacific Edge Appoints Chief Commercial Officer
Ryman Healthcare reports 1H26 results
Tower reports record FY25 result, increased dividends
NZ King Salmon Investments Ltd releases FY25 (Sept) results
RBNZ - OCR lowered to 2.25%
SVR - Savor Interim Results and Trading Update